(Q34075186)

English

NK-104: a novel synthetic HMG-CoA reductase inhibitor

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

title

NK-104: a novel synthetic HMG-CoA reductase inhibitor (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30 July 2017

Kajinami K

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060827

retrieved

30 July 2017

Mabuchi H

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060827

retrieved

30 July 2017

Saito Y

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060827

retrieved

30 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060827

retrieved

30 July 2017

published in

Expert Opinion on Investigational Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060827

retrieved

30 July 2017

volume

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060827

retrieved

30 July 2017

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060827

retrieved

30 July 2017

page(s)

2653-2661

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060827

retrieved

30 July 2017

cites work

Drug treatment of lipid disorders

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F13543784.9.11.2653

retrieved

21 January 2018

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F13543784.9.11.2653

retrieved

21 January 2018

NK-104, a newly developed HMG-CoA reductase inhibitor, suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in balloon-injured rabbit carotid artery

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F13543784.9.11.2653

retrieved

21 January 2018

Identifiers

DOI

10.1517/13543784.9.11.2653

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060827

retrieved

30 July 2017

PubMed publication ID

11060827

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060827

retrieved

30 July 2017

(Q34075186)

NK-104: a novel synthetic HMG-CoA reductase inhibitor

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)